James Daniel OSBORNE
11Patents
3h-index
50Co-inventors
59Inventor score
Filing activity: May 14, 2013 → Jan 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10544132B2 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Chemistry; Metallurgy | 7 | Active |
| US10526311B2 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Chemistry; Metallurgy | 6 | Active |
| US10981898B2 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Chemistry; Metallurgy | 4 | Active |
| US11261171B1 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Chemistry; Metallurgy | 2 | Active |
| US9663503B2 | 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11603367B2 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Chemistry; Metallurgy | 2 | Active |
| US10259806B2 | 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11787792B2 | 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12077526B2 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Chemistry; Metallurgy | 0 | Active |
| US10214509B2 | Amino-substituted heterocyclic derivatives as sodium channel inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12071429B2 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.